Narrative review / 2012
A review of low-level methylmercury exposure indicates potential effects on early growth and neurologic outcomes, with unclear findings for cardiovascular risk.
Researchers synthesized the published literature of original human epidemiologic research evaluating direct biomarkers of low-level methylmercury (MeHg) exposure. Evidence suggests possible effects of low-level MeHg on fetal growth in susceptible subgroups and infant growth in the first two years of life, while neurologic effects may vary by age, sex, and exposure timing. In contrast, no clear pattern was observed for cardiovascular disease risk across populations or specific endpoints, and studies of immunologic outcomes showed inconsistent results.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review of human epidemiologic studies
- Who was studied
- Human populations with low-level mercury exposure
- What was measured
- Fetal and infant growth, neurologic outcomes, cardiovascular disease risk, and immunologic effects
THE PAPER
Evidence on the human health effects of low-level methylmercury exposure.
Karagas MR, Choi AL, Oken E, Horvat M, Schoeny R, Kamai E, Cowell W, Grandjean P, Korrick S. Environ Health Perspect, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.